SCHEMBL24688808

SCHEMBL24688808

COc1ccc(/C(=C(/c2ccccc2)C(C)C)c2ccc(N3CCN(C(C)C)CC3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ESRRG P62508 13/20 0.50
▸ ESRRB O95718 6/20 0.50
▸ ESR1 P03372 4/20 0.50
▸ KCNH2 Q12809 4/20 0.49
▸ KMT2A Q03164 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ DRD2 P14416 1/20 0.47
▸ HTR2A P28223 1/20 0.47
▸ HTR1A P08908 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24688558 0.92 ESRRG (0.47) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL29968359 0.91 ESRRG (0.57) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL24688561 0.91 ESRRG (0.51) ESRRGESRRBESR1KCNH2KMT2A
SCHEMBL24688929 0.88 ESRRG (0.51) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL24688809 0.87 ESRRB (0.54) ESRRGESRRBESR1KCNH2
SCHEMBL24688923 0.86 ESRRG (0.65) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL24688916 0.85 ESRRG (0.49) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL24688812 0.83 ESRRG (0.50) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL24688913 0.83 ESRRG (0.57) ESRRGESRRBESR1KCNH2MAPT
SCHEMBL24688811 0.83 ESRRG (0.50) ESRRGESRRBESR1KCNH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022245124-A1 NOVEL ETHENE COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 재단법인 대구경북첨단의료산업진흥재단 2022-11-24 — — WO disclosed
Send feedback